These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10849511)

  • 1. Quantitative 3-dimensional contrast echocardiographic determination of myocardial mass at risk and residual infarct mass after reperfusion: experimental canine studies with intravenous contrast agent NC100100.
    Yao J; Teupe C; Takeuchi M; Avelar E; Sheahan M; Connolly R; Ostensen J; Pandian NG
    J Am Soc Echocardiogr; 2000 Jun; 13(6):570-81. PubMed ID: 10849511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional echocardiographic estimation of infarct mass based on quantification of dysfunctional left ventricular mass.
    Yao J; Cao QL; Masani N; Delabays A; Magni G; Acar P; Laskari C; Pandian NG
    Circulation; 1997 Sep; 96(5):1660-6. PubMed ID: 9315562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bulls-eye display and quantitation of myocardial perfusion defects using three-dimensional contrast echocardiography.
    Yao J; De Castro S; Delabays A; Masani N; Udelson JE; Pandian NG
    Echocardiography; 2001 Oct; 18(7):581-8. PubMed ID: 11737967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast.
    Villanueva FS; Glasheen WP; Sklenar J; Kaul S
    Circulation; 1993 Aug; 88(2):596-604. PubMed ID: 8339423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of myocardial perfusion by myocardial contrast echocardiography using harmonic power and the transvenous contrast agent SHU 563A in acute coronary occlusion and after reperfusion.
    Teupe C; Takeuchi M; Yao J; Abadi C; Avelar E; Fritzsch T; Pandian N
    Int J Cardiol; 2001 Feb; 77(2-3):231-7. PubMed ID: 11182187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of myocardial perfusion defects with real-time three-dimensional myocardial contrast echocardiography.
    Zhuang L; Xie MX; Wang WJ; Yang XX; Liu T
    Chin Med Sci J; 2006 Sep; 21(3):135-9. PubMed ID: 17086732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NC100100, a new echo contrast agent for the assessment of myocardial perfusion--safety and comparison with technetium-99m sestamibi single-photon emission computed tomography in a randomized multicenter study.
    Binder T; Assayag P; Baer F; Flachskampf F; Kamp O; Nienaber C; Nihoyannopoulos P; Piérard L; Steg G; Vanoverschelde JL; Van der Wouw P; Meland N; Marelli C; Lindvall K
    Clin Cardiol; 1999 Apr; 22(4):273-82. PubMed ID: 10198737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional myocardial contrast echocardiography: validation of in vivo risk and infarct volumes.
    Linka AZ; Ates G; Wei K; Firoozan S; Skyba DM; Kaul S
    J Am Coll Cardiol; 1997 Dec; 30(7):1892-9. PubMed ID: 9385924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of left ventricular perfusion defects using real-time three-dimensional myocardial contrast echocardiography.
    Camarano G; Jones M; Freidlin RZ; Panza JA
    J Am Soc Echocardiogr; 2002 Mar; 15(3):206-13. PubMed ID: 11875382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography.
    Kamp O; Lepper W; Vanoverschelde JL; Aeschbacher BC; Rovai D; Assayag P; Voci P; Kloster Y; Distante A; Visser CA
    Eur Heart J; 2001 Aug; 22(16):1485-95. PubMed ID: 11482922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myocardial contrast echocardiography with harmonic power Doppler and lung traversing SHU 563A ultrasound contrast medium for imaging myocardial perfusion disorders].
    Teupe C; Yao J; Takeuchi M; Abadi C; Avelar E; Fritzsch T; Pandian N
    Z Kardiol; 2000 Oct; 89(10):914-20. PubMed ID: 11098542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of intravenous myocardial contrast echocardiography in rats].
    Kobayashi H; Beppu S; Hirayama H; Yagura S; Kashiwagi Y; Kayano H; Ishikura F
    J Cardiol; 2001 Apr; 37(4):209-14. PubMed ID: 11337930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 Investigators.
    Marwick TH; Brunken R; Meland N; Brochet E; Baer FM; Binder T; Flachskampf F; Kamp O; Nienaber C; Nihoyannopoulos P; Pierard L; Vanoverschelde JL; van der Wouw P; Lindvall K
    J Am Coll Cardiol; 1998 Nov; 32(5):1260-9. PubMed ID: 9809934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia.
    Grayburn PA; Erickson JM; Escobar J; Womack L; Velasco CE
    J Am Coll Cardiol; 1995 Nov; 26(5):1340-7. PubMed ID: 7594052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary clinical experience in cardiology with sonazoid.
    Marelli C
    Am J Cardiol; 2000 Aug; 86(4A):10G-13G. PubMed ID: 10997345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiographic contrast agent, during acute myocardial infarction.
    Lindner JR; Firschke C; Wei K; Goodman NC; Skyba DM; Kaul S
    J Am Soc Echocardiogr; 1998 Jan; 11(1):36-46. PubMed ID: 9487468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast echocardiography can assess risk area and infarct size during coronary occlusion and reperfusion: experimental validation.
    Lafitte S; Higashiyama A; Masugata H; Peters B; Strachan M; Kwan OL; DeMaria AN
    J Am Coll Cardiol; 2002 May; 39(9):1546-54. PubMed ID: 11985921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time three-dimensional myocardial contrast echocardiography in assessment of myocardial perfusion defects.
    Chen LX; Wang XF; Nanda NC; Miller AP; Xie MX; Zhuang L; Yang Y; Wang J; Huang RQ; Yang Y; Fei HW; Wang LY
    Chin Med J (Engl); 2004 Mar; 117(3):337-41. PubMed ID: 15043769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage.
    Villanueva FS; Glasheen WP; Sklenar J; Kaul S
    Circulation; 1993 Dec; 88(6):2596-606. PubMed ID: 8252670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.